SEC Filing Summary

Michael H. Tardugno, Executive Chairman of the Board, acquired 7,169 shares of Imunon, Inc. common stock on September 25, 2026, at a price of $1.41 per share. This acquisition was made in lieu of cash for his base salary. Following this transaction, Mr. Tardugno directly owns 103,921 shares. Additionally, he holds 4,622 shares indirectly through an IRA. The filing (Document Type 4) was signed on September 28, 2026, by Jeffrey W Church as Attorney in Fact for Michael H. Tardugno.